Dual Role of SnoN in Mammalian Tumorigenesis

REFERENCES

• Agarwal, C., J. R. Hembree, E. A. Rorke, and R. L. Eckert. 1994. Transforming growth factor beta 1 regulation of metalloproteinase production in cultured human cervical epithelial cells. Cancer Res 54:943–949.
   PubMedGoogle Scholar
• Akhurst, R. J., and R. Derynck. 2001. TGF-beta signaling in cancer—a double-edged sword. Trends Cell Biol. 11:S44–S51.
   PubMed Web of Science ®Google Scholar
• Akiyoshi, S., H. Inoue, J. Hanai, K. Kusanagi, N. Nemoto, K. Miyazono, and M. Kawabata. 1999. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J. Biol. Chem. 274:35269–35277.
   PubMed Web of Science ®Google Scholar
• Attisano, L., and J. L. Wrana. 2002. Signal transduction by the TGF-beta superfamily. Science 296:1646–1647.
   PubMed Web of Science ®Google Scholar
• Azuma, H., S. Ehata, H. Miyazaki, T. Watabe, O. Maruyama, T. Imamura, T. Sakamoto, S. Kiyama, Y. Kiyama, T. Ubai, T. Inamoto, S. Takahara, Y. Itoh, Y. Otsuki, Y. Katsuoka, K. Miyazono, and S. Horie. 2005. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J. Natl. Cancer Inst 97:1734–1746.
   PubMedGoogle Scholar
• Bamburg, J. R. 1999. Proteins of the ADF/cofilin family: essential regulators of actin dynamics. Annu. Rev. Cell Dev. Biol. 15:185–230.
   PubMed Web of Science ®Google Scholar
• Barlat, I., B. Henglein, A. Plet, N. Lamb, A. Fernandez, F. McKenzie, J. Pouyssegur, A. Vie, and J. M. Blanchard. 1995. TGF-beta 1 and cAMP attenuate cyclin A gene transcription via a cAMP responsive element through independent pathways. Oncogene 11:1309–1318.
   PubMedGoogle Scholar
• Berdeaux, R. L., B. Diaz, L. Kim, and G. S. Martin. 2004. Active Rho is localized to podosomes induced by oncogenic Src and is required for their assembly and function. J. Cell Biol. 166:317–323.
   PubMedGoogle Scholar
• Bhowmick, N. A., M. Ghiassi, A. Bakin, M. Aakre, C. A. Lundquist, M. E. Engel, C. L. Arteaga, and H. L. Moses. 2001. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 12:27–36.
   PubMed Web of Science ®Google Scholar
• Boland, S., E. Boisvieux-Ulrich, O. Houcine, A. Baeza-Squiban, M. Pouchelet, D. Schoevaert, and F. Marano. 1996. TGF beta 1 promotes actin cytoskeleton reorganization and migratory phenotype in epithelial tracheal cells in primary culture. J. Cell Sci. 109:2207–2219.
   PubMedGoogle Scholar
• Bonni, S., H. R. Wang, C. G. Causing, P. Kavsak, S. L. Stroschein, K. Luo, and J. L. Wrana. 2001. TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat. Cell Biol. 3:587–595.
   PubMed Web of Science ®Google Scholar
• Boyer, P. L., C. Colmenares, E. Stavnezer, and S. H. Hughes. 1993. Sequence and biological activity of chicken snoN cDNA clones. Oncogene 8:457–466.
   PubMedGoogle Scholar
• Briand, P., O. W. Petersen, and B. van Deurs. 1987. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell Dev. Biol. 23:181–188.
   PubMed Web of Science ®Google Scholar
• Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550–553.
   PubMed Web of Science ®Google Scholar
• Chang, N. S., J. Mattison, H. Cao, N. Pratt, Y. Zhao, and C. Lee. 1998. Cloning and characterization of a novel transforming growth factor-beta1-induced TIAF1 protein that inhibits tumor necrosis factor cytotoxicity. Biochem. Biophys. Res. Commun. 253:743–749.
   PubMedGoogle Scholar
• Cohen, S. B., R. Nicol, and E. Stavnezer. 1998. A domain necessary for the transforming activity of SnoN is required for specific DNA binding, transcriptional repression and interaction with TAF(II)110. Oncogene 17:2505–2513.
   PubMedGoogle Scholar
• Colmenares, C., and E. Stavnezer. 1989. The ski oncogene induces muscle differentiation in quail embryo cells. Cell 59:293–303.
   PubMed Web of Science ®Google Scholar
• Colmenares, C., P. Sutrave, S. H. Hughes, and E. Stavnezer. 1991. Activation of the c-ski oncogene by overexpression. J. Virol. 65:4929–4935.
   PubMedGoogle Scholar
• Datto, M. B., Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and X. F. Wang. 1995. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92:5545–5549.
   PubMed Web of Science ®Google Scholar
• Debnath, J., S. K. Muthuswamy, and J. S. Brugge. 2003. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30:256–268.
   PubMed Web of Science ®Google Scholar
• DeClerck, Y. A., A. M. Mercurio, M. S. Stack, H. A. Chapman, M. M. Zutter, R. J. Muschel, A. Raz, L. M. Matrisian, B. F. Sloane, A. Noel, M. J. Hendrix, L. Coussens, and M. Padarathsingh. 2004. Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am. J. Pathol. 164:1131–1139.
   PubMed Web of Science ®Google Scholar
• Derynck, R., R. J. Akhurst, and A. Balmain. 2001. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 29:117–129.
   PubMed Web of Science ®Google Scholar
• Derynck, R., and Y. E. Zhang. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577–584.
   PubMed Web of Science ®Google Scholar
• Edmiston, J. S., W. A. Yeudall, T. D. Chung, and D. A. Lebman. 2005. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells. Cancer Res 65:4782–4788.
   PubMedGoogle Scholar
• Etienne-Manneville, S., and A. Hall. 2002. Rho GTPases in cell biology. Nature 420:629–635.
   PubMed Web of Science ®Google Scholar
• Fumagalli, S., L. Doneda, N. Nomura, and L. Larizza. 1993. Expression of the c-ski proto-oncogene in human melanoma cell lines. Melanoma Res. 3:23–27.
   PubMedGoogle Scholar
• Grunert, S., M. Jechlinger, and H. Beug. 2003. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol. 4:657–665.
   PubMed Web of Science ®Google Scholar
• Hattori, K., H. Lee, P. D. Hurn, B. J. Crain, R. J. Traystman, and A. C. DeVries. 2000. Cognitive deficits after focal cerebral ischemia in mice. Stroke 31:1939–1944.
   PubMed Web of Science ®Google Scholar
• He, J., S. B. Tegen, A. R. Krawitz, G. S. Martin, and K. Luo. 2003. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins. J. Biol. Chem. 278:30540–30547.
   PubMedGoogle Scholar
• Heissig, B., K. Hattori, M. Friedrich, S. Rafii, and Z. Werb. 2003. Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases. Curr. Opin. Hematol. 10:136–141.
   PubMed Web of Science ®Google Scholar
• Horne, M. C., K. L. Donaldson, G. L. Goolsby, D. Tran, M. Mulheisen, J. W. Hell, and A. F. Wahl. 1997. Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest. J. Biol. Chem. 272:12650–12661.
   PubMedGoogle Scholar
• Imoto, I., A. Pimkhaokham, Y. Fukuda, Z. Q. Yang, Y. Shimada, N. Nomura, H. Hirai, M. Imamura, and J. Inazawa. 2001. SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus. Biochem. Biophys. Res. Commun. 286:559–565.
   PubMedGoogle Scholar
• Irie, H. Y., R. V. Pearline, D. Grueneberg, M. Hsia, P. Ravichandran, N. Kothari, S. Natesan, and J. S. Brugge. 2005. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J. Cell Biol. 171:1023–1034.
   PubMed Web of Science ®Google Scholar
• Keeton, M. R., S. A. Curriden, A. J. van Zonneveld, and D. J. Loskutoff. 1991. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. J. Biol. Chem. 266:23048–23052.
   PubMedGoogle Scholar
• Kokura, K., S. C. Kaul, R. Wadhwa, T. Nomura, M. M. Khan, T. Shinagawa, T. Yasukawa, C. Colmenares, and S. Ishii. 2001. The Ski protein family is required for MeCP2-mediated transcriptional repression. J. Biol. Chem. 276:34115–34121.
   PubMedGoogle Scholar
• Krakowski, A. R., J. Laboureau, A. Mauviel, M. J. Bissell, and K. Luo. 2005. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins. Proc. Natl. Acad. Sci. USA 102:12437–12442.
   PubMedGoogle Scholar
• Liu, H., D. C. Radisky, C. M. Nelson, H. Zhang, J. E. Fata, R. A. Roth, and M. J. Bissell. 2006. Mechanism of Akt1 initiation of breast cancer invasion reveals a protumorigenic role for TSC 2. Proc. Natl. Acad. Sci. USA 103:4134–4139.
   PubMed Web of Science ®Google Scholar
• Lopez-Casillas, F., C. Riquelme, Y. Perez-Kato, M. V. Ponce-Castaneda, N. Osses, J. Esparza-Lopez, G. Gonzalez-Nunez, C. Cabello-Verrugio, V. Mendoza, V. Troncoso, and E. Brandan. 2003. β-Glycan expression is transcriptionally up-regulated during skeletal muscle differentiation. Cloning of murine betaglycan gene promoter and its modulation by MyoD, retinoic acid, and transforming growth factor-beta. J. Biol. Chem. 278:382–390.
   PubMedGoogle Scholar
• Luo, K., S. L. Stroschein, W. Wang, D. Chen, E. Martens, S. Zhou, and Q. Zhou. 1999. The Ski oncoprotein interacts with the Smad proteins to repress TGFβ signaling. Genes Dev. 13:2196–2206.
   PubMed Web of Science ®Google Scholar
• Ma, C., R. W. Tarnuzzer, and N. Chegini. 1999. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta1. Wound Repair Regen. 7:477–485.
   PubMed Web of Science ®Google Scholar
• Massague, J., and D. Wotton. 2000. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19:1745–1754.
   PubMed Web of Science ®Google Scholar
• Moustakas, A., K. Pardali, A. Gaal, and C. H. Heldin. 2002. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol. Lett. 82:85–91.
   PubMed Web of Science ®Google Scholar
• Nomura, N., S. Sasamoto, S. Ishii, T. Date, M. Matsui, and R. Ishizaki. 1989. Isolation of human cDNA clones of ski and the ski-related gene, sno. Nucleic Acids Res. 17:5489–5500.
   PubMedGoogle Scholar
• Oemar, B. S., A. Werner, J. M. Garnier, D. D. Do, N. Godoy, M. Nauck, W. Marz, J. Rupp, M. Pech, and T. F. Luscher. 1997. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 95:831–839.
   PubMed Web of Science ®Google Scholar
• Pearson-White, S. 1993. SnoI, a novel alternatively spliced isoform of the ski protooncogene homolog, sno. Nucleic Acids Res. 21:4632–4638.
   PubMed Web of Science ®Google Scholar
• Pearson-White, S., and R. Crittenden. 1997. Proto-oncogene Sno expression, alternative isoforms and immediate early serum response. Nucleic Acids Res. 25:2930–2937.
   PubMed Web of Science ®Google Scholar
• Pertovaara, L., A. Kaipainen, T. Mustonen, A. Orpana, N. Ferrara, O. Saksela, and K. Alitalo. 1994. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J. Biol. Chem. 269:6271–6274.
   PubMed Web of Science ®Google Scholar
• Pertovaara, L., L. Sistonen, T. J. Bos, P. K. Vogt, J. Keski-Oja, and K. Alitalo. 1989. Enhanced jun gene expression is an early genomic response to transforming growth factor β stimulation. Mol. Cell. Biol. 9:1255–1262.
   PubMed Web of Science ®Google Scholar
• Poser, I., T. Rothhammer, S. Dooley, R. Weiskirchen, and A. K. Bosserhoff. 2005. Characterization of Sno expression in malignant melanoma. Int. J. Oncol. 26:1411–1417.
   PubMedGoogle Scholar
• Savagner, P. 2001. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23:912–923.
   PubMed Web of Science ®Google Scholar
• Sehgal, I., and T. C. Thompson. 1999. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines. Mol. Biol. Cell 10:407–416.
   PubMed Web of Science ®Google Scholar
• Shen, X., J. Li, P. P. Hu, D. Waddell, J. Zhang, and X. F. Wang. 2001. The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation. J. Biol. Chem. 276:15362–15368.
   PubMed Web of Science ®Google Scholar
• Shimizu, S., Y. Nishikawa, K. Kuroda, S. Takagi, K. Kozaki, S. Hyuga, S. Saga, and M. Matsuyama. 1996. Involvement of transforming growth factor beta1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells. Cancer Res 56:3366–3370.
   PubMedGoogle Scholar
• Shinagawa, T., H.-D. Dong, M. Xu, T. Maekawa, and S. Ishii. 2000. The sno gene, which encodes a component of the histone deacetylation complex, acts as a tumor suppressor in mice. EMBO J. 19:2280–2291.
   PubMedGoogle Scholar
• Siegel, P. M., and J. Massague. 2003. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 3:807–821.
   PubMed Web of Science ®Google Scholar
• Stroschein, S. L., S. Bonni, J. L. Wrana, and K. Luo. 2001. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev. 15:2822–2836.
   PubMed Web of Science ®Google Scholar
• Stroschein, S. L., W. Wang, S. Zhou, Q. Zhou, and K. Luo. 1999. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science 286:771–774.
   PubMed Web of Science ®Google Scholar
• Sun, Y., X. Liu, E. N. Eaton, W. S. Lane, H. F. Lodish, and R. A. Weinberg. 1999. Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling. Mol. Cell 4:499–509.
   PubMedGoogle Scholar
• Sun, Y., X. Liu, E. Ng-Eaton, H. F. Lodish, and R. A. Weinberg. 1999. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc. Natl. Acad. Sci. USA 96:12442–12447.
   PubMed Web of Science ®Google Scholar
• Thiery, J. P. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2:442–454.
   PubMed Web of Science ®Google Scholar
• Thiery, J. P., and D. Chopin. 1999. Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev. 18:31–42.
   PubMed Web of Science ®Google Scholar
• Wakefield, L. M., and A. B. Roberts. 2002. TGF-beta signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12:22–29.
   PubMed Web of Science ®Google Scholar
• Wilkinson, D. S., S. K. Ogden, S. A. Stratton, J. L. Piechan, T. T. Nguyen, G. A. Smulian, and M. C. Barton. 2005. A direct intersection between p53 and transforming growth factor beta pathways targets chromatin modification and transcription repression of the alpha-fetoprotein gene. Mol. Cell. Biol. 25:1200–1212.
   PubMedGoogle Scholar
• Wu, J. W., A. R. Krawitz, J. Chai, W. Li, F. Zhang, K. Luo, and Y. Shi. 2002. Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling. Cell 111:357–367.
   PubMed Web of Science ®Google Scholar
• Xu, W., K. Angelis, D. Danielpour, M. M. Haddad, O. Bischof, J. Campisi, E. Stavnezer, and E. E. Medrano. 2000. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. Proc. Natl. Acad. Sci. USA 97:5924–5929.
   PubMedGoogle Scholar
• Yoeli-Lerner, M., G. K. Yiu, I. Rabinovitz, P. Erhardt, S. Jauliac, and A. Toker. 2005. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol. Cell 20:539–550.
   PubMed Web of Science ®Google Scholar
• Zavadil, J., and E. P. Bottinger. 2005. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24:5764–5774.
   PubMed Web of Science ®Google Scholar
• Zhang, F., M. Lundin, A. Ristimaki, P. Heikkila, J. Lundin, J. Isola, H. Joensuu, and M. Laiho. 2003. Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas. Cancer Res 63:5005–5010.
   PubMedGoogle Scholar
• Zhu, Q., S. Pearson-White, and K. Luo. 2005. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells. Mol. Cell. Biol. 25:10731–10744.
   PubMedGoogle Scholar